News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


PHARMAC steps up to help meet Government cancer treatment g

7 December 2012

Media release

PHARMAC steps up to help meet Government cancer treatment goal

Recent decisions by PHARMAC will have a positive effect on cancer treatment in New Zealand.

PHARMAC has removed the Special Authority funding requirements from seven cancer treatments, and from the diabetes treatment pioglitazone. Special Authorities define the clinical criteria patients must meet to receive some funded medicines. Clinicians must complete a Special Authority application and receive approval before prescribing in order for the patient to receive the funded medicine.

PHARMAC’s medical director Dr Peter Moodie, says the lifting of these funding restrictions is a positive step.

“Removing the Special Authorities from these cancer treatments will significantly reduce administrative demands on the hospital oncologists and haematologists who routinely prescribe these drugs,” says Dr Moodie.

“In addition, one of the medicines being de-restricted is capecitabine, a tablet which can be used in place of 5-flourouracil, a chemotherapy infusion that patients need to receive in hospitals or special treatment centres. Patients prescribed capecitabine will have a more convenient treatment option which they can take at home and this is particularly helpful for rural people and reduces their costs of receiving treatment.

“Removing the Special Authority restrictions will also free up hospital resources that can be used to treat more patients overall, which will help DHBs achieve the Government health priority to reduce cancer treatment waiting times.”

The medicines having Special Authority funding requirements removed are:

o Anagrelide hydrochloride – primarily used to treat thrombothycaemia (overproduction of platelets)

o Gemcitabine hydrochloride - used to treat a variety of cancers including bladder, breast, pancreas, lymphoma, lung and ovarian cancer.

o Irinotecan - primarily used to treat bowel and pancreatic cancer.

o Oxaliplatin - primarily used to treat bowel, pancreas and stomach cancer.

o Vinorelbine - primarily used to treat lymphoma, lung and breast cancer

o Capecitabine – primarily used to treat breast, bowel and stomach cancer

o Octreotide – primarily used in cancer for endocrine tumours and for palliation of symptoms in patients with malignant bowel obstruction.

Overall, removing the Special Authorities from these medicines will reduce the number of applications by about 4000 per year.

The Special Authorities were removed from these treatments from 1 December 2012 meaning that they are now fully funded by DHBs for any cancer patients. In addition, capecitabine is funded for any patient in the community when prescribed by a specialist.

Dr Moodie says that making access easier, such as by removing Special Authorities, usually results in more patients being prescribed the treatment.

“Effectively, this means we are giving doctors treating cancer greater discretion in how they choose to treat their patients, in the knowledge that it will be funded for them.”

Pioglitazone is a treatment that increases the body’s sensitivity to insulin, and is mainly used to treat Type 2 diabetes.

As with the cancer treatments, the Special Authority on pioglitazone was removed from 1 December.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Game Review: Midsomer Murders Meets First Year Philosophy

Developed by The Chinese Room, Everybody's Gone to the Rapture sees the player exploring what appears to be a recently abandoned idyllic English village trying to figure out where everybody's gone. Spoiler: they've gone to the rapture. (On a serious note, this review contains plot spoilers.) More>>

Scoop Review Of Books: Clear Science

It was really after his move to Wellington, to Victoria University, that it became apparent that Sir Paul Cllaghan was much more than an eminent physicist... More>>

ALSO:

Francis Cook: Weekend SportzMania! All Blacks! Netball!

Sports were on all weekend. I normally don’t write about sports but with Richie McCaw tipped to be the next Prime Minister, and Colin Craig arguing sports are almost as important as politics, I thought “what better time to start!” More>>

ALSO:

Beervana: Aussie Pav Beer Declared Taste Of NZ

In a surprising upset, an Australian beer modelled on the pavlova, created by Brisbane brewery Newstead Brewing, the 250 Beers blog and Scratch Bar, has been announced the winner at the Beervana craft beer festival ‘Flag Brew’ competition, which challenged media and brewing teams to capture the distinctive taste of New Zealand. More>>

ALSO:

Transport: Air NZ Teams Up With All Blacks For Men In Black Video

Inspired by the Columbia Pictures global film franchise Men in Black, Air New Zealand’s latest safety instalment features All Blacks’ Captain Richie McCaw and Dan Carter as Men in Black agents. More>>

ALSO:

World Champions: BRADAS Of Identity Company Take On The World And Win Gold

This is only the second time since NZ has qualified for the HHI world finals that NZ has taken home a GOLD medal in this division. REQUEST Dance Crew being the only other NZ crew to achieve this. New Zealands only other medal this year was Silver for the Royal Family in a very close final in the Megacrew division. More>>

Scoop Review Of Books: Contrary To Popular Belief - Lloyd Geering

Many older Dunediners like myself, and indeed older Presbyterians and others throughout the country, will remember the controversy aroused by the articles and speeches of Professor Geering, Principal of Knox College Theological Hall in the late 1960s... More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news